• 7455 Citations
  • 36 h-Index
1987 …2024
If you made any changes in Pure these will be visible here soon.

Research Outputs 1987 2019

Filter
Review article
2019

Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer

Al-Mansouri, L. & Gurney, H., 1 Dec 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, 6, p. 288-295 8 p.

Research output: Contribution to journalReview articleResearchpeer-review

Castration
Prostatic Neoplasms
docetaxel
Drug Therapy
Taxoids
2017

Dose considerations for anti-cancer drugs in metastatic prostate cancer

Crumbaker, M. & Gurney, H., 1 Aug 2017, In : Prostate. 77, 11, p. 1199-1204 6 p.

Research output: Contribution to journalReview articleResearchpeer-review

docetaxel
Prostatic Neoplasms
Pharmaceutical Preparations
Neoplasms
Quality of Life

Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure

Rowland, A., van Dyk, M., Mangoni, A. A., Miners, J. O., McKinnon, R. A., Wiese, M. D., Rowland, A., Kichenadasse, G., Gurney, H. & Sorich, M. J., 2017, In : Expert Opinion on Drug Metabolism and Toxicology. 13, 1, p. 31-49 19 p.

Research output: Contribution to journalReview articleResearchpeer-review

Pharmacokinetics
Phosphotransferases
Expert Testimony
Protein Kinase Inhibitors
Metabolism
2015

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia

Parente, P., Gurney, H., Ng, S. & Bahre, M., 1 Sep 2015, In : Asia-Pacific Journal of Clinical Oncology. 11, 3, p. 199-207 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Prostatic Neoplasms
Castration
docetaxel
Nurses
Therapeutics
2014

Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer

Parente, P., Parnis, F. & Gurney, H., 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 205-215 11 p.

Research output: Contribution to journalReview articleResearchpeer-review

Castration
Prostatic Neoplasms
docetaxel
Drug Therapy
Radium

Use of targeted therapies for advanced renal cell carcinoma in the asia-pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia

Ye, D., Eto, M., Chung, J. S., Kimura, G., Chang, W. C., Chang, Y. H., Pang, S. T., Lee, J. L., Niu, Y., Gurney, H. & Uemura, H., 2014, In : Clinical Genitourinary Cancer. 12, 4, p. 225-233 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Korea
Taiwan
Renal Cell Carcinoma
China
Japan
2012

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

Parente, P., Parnis, F. & Gurney, H., 2012, In : Asia-Pacific Journal of Clinical Oncology. 8, 1, p. 31-42 12 p.

Research output: Contribution to journalReview articleResearchpeer-review

docetaxel
Castration
Prostatic Neoplasms
Therapeutics
Drug Therapy

Evidence for therapeutic drug monitoring of targeted anticancer therapies

Gao, B., Yeap, S., Clements, A., Balakrishnar, B., Wong, M. & Gurney, H., 10 Nov 2012, In : Journal of Clinical Oncology. 30, 32, p. 4017-4025 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Drug Monitoring
Pharmacokinetics
Pharmaceutical Preparations
Immunosuppressive Agents
Intravenous Injections
2011

Metformin in prostate cancer: Two for the price of one

Clements, A., Gao, B., Yeap, S. H. O., Wong, M. K. Y., Ali, S. S. & Gurney, H., Dec 2011, In : Annals of Oncology. 22, 12, p. 2556-2560 5 p., mdr037.

Research output: Contribution to journalReview articleResearchpeer-review

Metformin
Prostatic Neoplasms
Androgens
Antineoplastic Agents
Clinical Trials

Moving towards dose individualization of tyrosine kinase inhibitors

Klümpen, H. J., Samer, C. F., Mathijssen, R. H. J., Schellens, J. H. M. & Gurney, H., Jun 2011, In : Cancer Treatment Reviews. 37, 4, p. 251-260 10 p.

Research output: Contribution to journalReview articleResearchpeer-review

Protein-Tyrosine Kinases
Pharmacokinetics
Biomarkers
Molecular Targeted Therapy
Therapeutics
2010

Inhibitors of mTOR

Klümpen, H. J., Beijnen, J. H., Gurney, H. & Schellens, J. H. M., Dec 2010, In : Oncologist. 15, 12, p. 1262-1269 8 p.

Research output: Contribution to journalReview articleResearchpeer-review

Sirolimus
Pharmaceutical Preparations
Pharmacogenetics
Drug Interactions
Renal Cell Carcinoma
2008

Dose calculation of anticancer drugs

Gao, B., Klumpen, H. J. & Gurney, H., Oct 2008, In : Expert Opinion on Drug Metabolism and Toxicology. 4, 10, p. 1307-1319 13 p.

Research output: Contribution to journalReview articleResearchpeer-review

Pharmaceutical Preparations
Drug Monitoring
Body Surface Area
Poisons
Therapeutic Uses
2007

Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: Possible evidence of graft-versus-tumour effect

Goodwin, A., Gurney, H. & Gottlieb, D., Feb 2007, In : Internal Medicine Journal. 37, 2, p. 127-129 3 p.

Research output: Contribution to journalReview articleResearchpeer-review

Germ Cell and Embryonal Neoplasms
Bone Marrow
Transplants
Neoplasms
Homologous Transplantation

Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

Desai, J., Gurney, H., Pavlakis, N., Mcarthur, G. A. & Davis, I. D., Dec 2007, In : Asia-Pacific Journal of Clinical Oncology. 3, 4, p. 167-176 10 p.

Research output: Contribution to journalReview articleResearchpeer-review

Gastrointestinal Stromal Tumors
Renal Cell Carcinoma
Hand-Foot Syndrome
Therapeutics
Lethargy
1996

Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative

Gurney, H., 1996, In : Journal of Clinical Oncology. 14, 9, p. 2590-2611 22 p.

Research output: Contribution to journalReview articleResearchpeer-review

Body Surface Area
Drug Monitoring
Pharmaceutical Preparations
Pharmacokinetics
docetaxel
1993

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice -part 2

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Feb 1993, In : Annals of Oncology. 4, 2, p. 103-115 13 p.

Research output: Contribution to journalReview articleResearchpeer-review

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice - part 1

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Jan 1993, In : Annals of Oncology. 4, 1, p. 23-34 12 p.

Research output: Contribution to journalReview articleResearchpeer-review

1990

Hemopoietic growth factors: Their clinical role

Gurney, H. & Crowther, D., 1990, In : Drugs of the Future. 15, 6, p. 581-595 15 p.

Research output: Contribution to journalReview articleResearchpeer-review